411 related articles for article (PubMed ID: 28340332)
21. AFF4 globally affects the release of paused RNA polymerase II in HEL cells.
Yang ZM; Zhang G; Wei G; Jing LL; Yu M
Yi Chuan; 2023 Aug; 45(8):658-668. PubMed ID: 37609817
[TBL] [Abstract][Full Text] [Related]
22. A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.
Li Z; Lu H; Zhou Q
Mol Cell Biol; 2016 Feb; 36(7):1194-205. PubMed ID: 26830226
[TBL] [Abstract][Full Text] [Related]
23. Latent HIV-1 TAR Regulates 7SK-responsive P-TEFb Target Genes and Targets Cellular Immune Responses in the Absence of Tat.
Eilebrecht S; Benecke BJ; Benecke AG
Genomics Proteomics Bioinformatics; 2017 Oct; 15(5):313-323. PubMed ID: 29037489
[TBL] [Abstract][Full Text] [Related]
24. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
[TBL] [Abstract][Full Text] [Related]
26. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
[TBL] [Abstract][Full Text] [Related]
27. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.
Muniz L; Egloff S; Ughy B; Jády BE; Kiss T
PLoS Pathog; 2010 Oct; 6(10):e1001152. PubMed ID: 20976203
[TBL] [Abstract][Full Text] [Related]
28. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
Fong YW; Zhou Q
Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
[TBL] [Abstract][Full Text] [Related]
29. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
30. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
Mousseau G; Valente ST
Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.
Bartholomeeusen K; Xiang Y; Fujinaga K; Peterlin BM
J Biol Chem; 2012 Oct; 287(43):36609-16. PubMed ID: 22952229
[TBL] [Abstract][Full Text] [Related]
32. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
33. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
Shortridge MD; Wille PT; Jones AN; Davidson A; Bogdanovic J; Arts E; Karn J; Robinson JA; Varani G
Nucleic Acids Res; 2019 Feb; 47(3):1523-1531. PubMed ID: 30481318
[TBL] [Abstract][Full Text] [Related]
34. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
[TBL] [Abstract][Full Text] [Related]
35. P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.
O'Brien SK; Cao H; Nathans R; Ali A; Rana TM
J Biol Chem; 2010 Sep; 285(39):29713-20. PubMed ID: 20551309
[TBL] [Abstract][Full Text] [Related]
36. ELL-associated factors EAF1/2 negatively regulate HIV-1 transcription through inhibition of Super Elongation Complex formation.
Liu R; Chen C; Li Y; Huang Q; Xue Y
Biochim Biophys Acta Gene Regul Mech; 2020 May; 1863(5):194508. PubMed ID: 32087315
[TBL] [Abstract][Full Text] [Related]
37. The control of HIV transcription: keeping RNA polymerase II on track.
Ott M; Geyer M; Zhou Q
Cell Host Microbe; 2011 Nov; 10(5):426-35. PubMed ID: 22100159
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription.
Qi S; Li Z; Schulze-Gahmen U; Stjepanovic G; Zhou Q; Hurley JH
Nat Commun; 2017 Jan; 8():14076. PubMed ID: 28134250
[TBL] [Abstract][Full Text] [Related]
39. Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex.
Schulze-Gahmen U; Echeverria I; Stjepanovic G; Bai Y; Lu H; Schneidman-Duhovny D; Doudna JA; Zhou Q; Sali A; Hurley JH
Elife; 2016 Oct; 5():. PubMed ID: 27731797
[TBL] [Abstract][Full Text] [Related]
40. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.
Sedore SC; Byers SA; Biglione S; Price JP; Maury WJ; Price DH
Nucleic Acids Res; 2007; 35(13):4347-58. PubMed ID: 17576689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
